Web Results

en.wikipedia.org/wiki/Mallinckrodt

Mallinckrodt Pharmaceuticals, based in Staines-upon-Thames, England, with its U.S. headquarters in St. Louis, Missouri, produces specialty pharmaceutical products, including generic drugs and imaging agents. Mallinckrodt manufactures and distributes products used in diagnostic procedures and in the treatment of pain ...

www.mallinckrodt.com

As a global specialty biopharmaceutical company, Mallinckrodt has been making the complex simple for nearly 150 years. Visit the website to learn more.

www.mallinckrodt.com/careers

Please be advised that Mallinckrodt Pharmaceuticals LLC does not interview any candidate through email, nor request any confidential personal information via email. Our available positions are posted on legitimate job boards such as our company website, INDEED & LinkedIn. In the event of a fit, our recruitment team ...

www.mallinckrodt.com/about/history

The Mallinckrodt story goes back nearly 150 years. Visit the website to learn about our rich history and growth throughout the years.

www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=21609

Mallinckrodt LLC manufactures and distributes products used in diagnostic procedures, and in the treatment of pain and related conditions. It offers addiction treatment products, and specialty generics and pharmaceuticals; and active pharmaceutical ingredients, including medicinal narcotics, acetaminophen/ paracetamol, ...

www.linkedin.com/company/mallinckrodt

Learn about working at Mallinckrodt Pharmaceuticals. Join LinkedIn today for free. See who you know at Mallinckrodt Pharmaceuticals, leverage your professional network, and get hired.

www.glassdoor.com/Reviews/Mallinckrodt-Pharmaceuticals-Reviews-E669747.htm

Jan 17, 2018 ... 253 Mallinckrodt Pharmaceuticals reviews. A free inside look at company reviews and salaries posted anonymously by employees.

www.reuters.com/article/us-sucampo-m-a-malinckrodt/mallinckrodt-to-buy-sucampo-for-about-840-million-idUSKBN1EK0SK

Dec 26, 2017 ... Mallinckrodt Plc (MNK.N) said on Tuesday it would buy Sucampo Pharmaceuticals Inc SCMP.O for about $840 million to snap up constipation drug Amitiza and a clutch of experimental rare disease treatments, as it battles declining sales of its biggest drug, Acthar.

www.justice.gov/opa/pr/mallinckrodt-agrees-pay-record-35-million-settlement-failure-report-suspicious-orders

Jul 11, 2017 ... Mallinckrodt LLC, a pharmaceutical manufacturer and one of the largest manufacturers of generic oxycodone, agreed to pay $35 million to settle allegations that it violated certain provisions of the Controlled Substances Act ( CSA) that are subject to civil penalties, Attorney General Jeff Sessions of the ...